BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33253820)

  • 1. Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile.
    Federico C; Sun J; Muz B; Alhallak K; Cosper PF; Muhammad N; Jeske A; Hinger A; Markovina S; Grigsby P; Schwarz JK; Azab AK
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1483-1494. PubMed ID: 33253820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of cisplatin-loaded mucoadhesive nanofibers for local chemotherapy of cervical cancers in mice.
    Zong S; Wang X; Yang Y; Wu W; Li H; Ma Y; Lin W; Sun T; Huang Y; Xie Z; Yue Y; Liu S; Jing X
    Eur J Pharm Biopharm; 2015 Jun; 93():127-35. PubMed ID: 25843238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 1/2 Study of Carbon Ion Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Uterine Cervical Squamous Cell Carcinoma (Protocol 1302).
    Okonogi N; Wakatsuki M; Kato S; Karasawa K; Miyasaka Y; Murata H; Nakano T; Kamada T; Shozu M;
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):631-639. PubMed ID: 30825494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    Ryu SY; Lee WM; Kim K; Park SI; Kim BJ; Kim MH; Choi SC; Cho CK; Nam BH; Lee ED
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e577-81. PubMed ID: 21840137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of platinum in human gynecologic tissues and pelvic lymph nodes after administration of cisplatin.
    Tokuhashi Y; Kikkawa F; Ishikawa H; Tamakoshi K; Hattori S; Matsuzawa K; Inoue T; Suganuma N; Tomoda Y
    Gynecol Obstet Invest; 1997; 44(4):270-4. PubMed ID: 9415527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
    Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
    J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment determines response to a heat-activated thermosensitive liposome formulation of cisplatin in cervical carcinoma.
    Dou YN; Chaudary N; Chang MC; Dunne M; Huang H; Jaffray DA; Milosevic M; Allen C
    J Control Release; 2017 Sep; 262():182-191. PubMed ID: 28760449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical pharmacokinetic study of cisplatin in enhancing cervical cancer radiosensitivity].
    Lu JL; Yang F
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1170-2. PubMed ID: 16939913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin delivery by biodegradable polymer implant is superior to systemic delivery by osmotic pump or i.p. injection in tumor-bearing mice.
    Yapp DT; Lloyd DK; Zhu J; Lehnert SM
    Anticancer Drugs; 1998 Oct; 9(9):791-6. PubMed ID: 9840725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-loaded polymeric complex micelles with a modulated drug/copolymer ratio for improved in vivo performance.
    Chen Q; Luo L; Xue Y; Han J; Liu Y; Zhang Y; Yin T; Wang L; Cun D; Gou J; He H; Tang X
    Acta Biomater; 2019 Jul; 92():205-218. PubMed ID: 31071475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system.
    Ning S; Yu N; Brown DM; Kanekal S; Knox SJ
    Radiother Oncol; 1999 Feb; 50(2):215-23. PubMed ID: 10368046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model.
    Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL
    Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer.
    Chang CE; Hsieh CM; Chen LC; Su CY; Liu DZ; Jhan HJ; Ho HO; Sheu MT
    Drug Deliv; 2018 Nov; 25(1):632-643. PubMed ID: 29463123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines.
    Zhang T; Cai S; Groer C; Forrest WC; Yang Q; Mohr E; Douglas J; Aires D; Axiak-Bechtel SM; Selting KA; Swarz JA; Tate DJ; Bryan JN; Forrest ML
    J Pharm Sci; 2016 Jun; 105(6):1891-1900. PubMed ID: 27155765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 1/2 Study of the Addition of Cisplatin to Adjuvant Chemotherapy With Image Guided High-Precision Radiation Therapy for Completely Resected Gastric Cancer.
    Goody RB; MacKay H; Pitcher B; Oza A; Siu LL; Kim J; Wong RK; Chen E; Swallow C; Knox J; Kassam Z; Cummings B; Feld R; Hedley D; Liu G; Krzyzanowska MK; Dinniwell R; Brade AM; Dawson LA; Pintilie M; Ringash J
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):994-1002. PubMed ID: 27745984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.